Francine M. Foss – FDA 483, Feb 3, 2023

Francine M. Foss, a clinical investigator in New Haven, CT, was inspected from January 30 to February 3, 2023. The inspection revealed a significant failure to maintain accurate case histories and data pertinent to a clinical investigation. This included incorrect disease staging and tumor burden calculations for multiple subjects in the Electronic Data Capture system.